Cipla EU to acquire additional 19.16 percent stake in Cipla Maroc Ruchika Sharma6 Aug 2022 5:15 PM ISTNew Delhi: Cipla (EU) Limited, wholly owned subsidiary of the Company in UK, has agreed to acquire an additional 19.16% stake in Cipla Maroc SA, ...
Cipla gets CDSCO panel nod to study Rizatriptan Benzoate Orally Disintegrating Tablet Rahul Verma4 Aug 2022 6:00 PM ISTGranting approval to conduct bioequivalence (BE) study of Rizatriptan Benzoate Orally Disintegrating Tablets 5mg, the Subject Expert Committee (SEC)...
Cipla names Dr Mandar Purushottam Vaidya as Additional, Independent Director Ruchika Sharma30 July 2022 5:02 PM ISTNew Delhi: Cipla has announced the appointment of Dr. Mandar Purushottam Vaidya as an additional and independent director of the Company for period of...
Cipla Health to acquire Endura Mass from Medinnbelle Hervalcare Rahul Verma15 July 2022 4:58 PM ISTCipla Limited has announced that Cipla Health Limited (CHL), wholly owned subsidiary and consumer healthcare arm of the Company has signed definitive...
Cipla to buy nutritional supplement brand Endura Mass Ruchika Sharma15 July 2022 1:00 PM ISTThis acquisition is in line with Cipla's strategic imperative to augment the Company's wellness portfolio for bringing about a shift from an illness...
Madras HC refuses to stop Sun Pharma from using word 'Respules' Dr. Nandita Mohan12 July 2022 6:30 PM ISTThe Madras High Court has declined to restrain Sun Pharmaceuticals Industries Limited in Nandanam here from using the word 'Respules' in its business...
Health Bulletin 12/July/2022 Dr. Nandita Mohan12 July 2022 5:47 PM ISTHere are the Top health stories for the day:ICMR launches national registry of multiple sclerosis and allied demyelinating disordersThe Indian...
Sun versus Cipla: Madras HC refuses to stop Sun Pharma from using word 'Respules' Ruchika Sharma12 July 2022 12:13 PM ISTPassing interim orders, the judge said the evidence on record indicates prima facie that the word 'Respules' is used both by other manufacturers and...
Cipla Indore plant gets 2 USFDA observations Ruchika Sharma5 July 2022 12:17 PM ISTMumbai: Pharma major, Cipla, has recently announced that the United States Food and Drug Administration (USFDA) has issued 2 observations after a...
Cipla to purchase additional stake in GoApptiv for Rs 26 crore Ruchika Sharma28 Jun 2022 2:00 PM ISTThe company's earlier investment in GoApptiv in June 2020 has yielded growth and expanded Cipla's channel reach across lower tier towns in India.
Cipla, Macleods HIV child treatments approved in South Africa Ruchika Sharma27 Jun 2022 12:30 PM ISTNew Delhi: South Africa, which has the world's biggest number of people infected with HIV, has approved Cipla Ltd.'s quadrimune, a treatment for...
Cipla to purchase 21.05 percent stake in Achira Labs to develop affordable medical kits in India Ruchika Sharma18 Jun 2022 11:22 AM ISTMumbai: Cipla Limited has announced that the company has signed definitive agreements for acquisition of 21.05% stake (on a fully diluted basis) for...
